Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

Pharmacodynamic studies have shown that persistently high platelet reactivity is common in patients with diabetes in spite of clopidogrel treatment. Clinical trials have not convincingly demonstrated that clopidogrel benefits patients with diabetes as much patients without diabetes.
Original languageEnglish
JournalJ A M A: The Journal of the American Medical Association
Volume308
Issue number9
Pages (from-to)882-9
Number of pages8
ISSN0098-7484
DOIs
Publication statusPublished - 2012

ID: 48453205